PE
NVRO

Point72 Europe’s NEVRO CORP. NVRO Stock Holding History

Point72 Europe’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-73,800
Closed -$1.88M – 132
2023
Q2 		$1.88M Buy
+73,800
New +$2.13M 0.25% 86

Other funds holding NVRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Point72 Europe's NVRO Position: Q3 2023 in Review

Point72 Europe sold out of NEVRO CORP. (NVRO) in Q3 2023, closing a stake of 73,800 shares — an estimated $1.88M sold.

Point72 Europe first reported a position in NVRO in Q2 2023 and held it in 1 quarter. The position peaked at $1.88M in Q2 2023. 136 funds tracked by Wall St. Rank hold NVRO as of Q3 2023.

  • Point72 Europe reported no remaining NEVRO CORP. position as of Q3 2023 after selling out during the quarter.
  • Point72 Europe sold 73,800 NEVRO CORP. shares in Q3 2023, an estimated $1.88M.
  • Point72 Europe first reported a position in NEVRO CORP. in Q2 2023 and held it in 1 quarter.
  • Point72 Europe's NEVRO CORP. position peaked at $1.88M in Q2 2023.
  • 136 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2023.

Based on Point72 Europe's 13F filing for Q3 2023, filed 14 Nov 2023.